Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

210.67 -7.44 (-3.41%)

Streaming Delayed Price Updated: 10:24 AM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Insulet, Uber And A Financial Stock On CNBC's 'Final Trades' ↗

November 05, 2025

Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade.

Via Benzinga

Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow

November 04, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting results this Thursday before market hours. Here’s what investors should know.

Via StockStory

Peering Into Insulet Corp's Recent Short Interest ↗

October 31, 2025

Via Benzinga

$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

October 30, 2025

Via Benzinga

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

October 30, 2025

From Insulet Corporation

Via Business Wire

Price Over Earnings Overview: Insulet ↗

September 30, 2025

Via Benzinga

INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum ↗

October 29, 2025

Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors.

Via Chartmill

1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off

October 27, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing ↗

October 25, 2025

Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers.

Via Chartmill

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

October 23, 2025

From Insulet Corporation

Via Business Wire

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗

October 21, 2025

Via Benzinga

Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD) ↗

October 20, 2025

Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth.

Via Chartmill

Insulet to Host Investor Day on November 20, 2025

October 10, 2025

From Insulet Corporation

Via Business Wire

Discover which S&P500 stocks are making waves on Thursday. ↗

October 09, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

October 01, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 29, 2025

Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization...

Via Benzinga

A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts ↗

September 29, 2025

6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives.

Via Benzinga

Insulet Corp (NASDAQ:PODD): An Affordable Growth Stock with Strong Profitability ↗

September 27, 2025

Insulet Corp (PODD) exemplifies affordable growth with strong revenue & EPS expansion, high profitability, and a valuation justified by its industry-leading potential.

Via Chartmill

Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Via StockStory

Topics World Trade

Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today ↗

September 19, 2025

Via Benzinga

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

September 18, 2025

From Insulet Corporation

Via Business Wire

Why Insulet (PODD) Shares Are Falling Today

September 17, 2025

Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 4.3% in the morning session after the company announced a change in its chief financial officer, a move that appeared to...

Via StockStory

Topics Economy

Tech Stocks Slip, Small Caps Soar Ahead Of Fed Rate Decision: What's Moving Markets Wednesday? ↗

September 17, 2025

Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&P 500 hovered near record levels as investors braced for the Federal...

Via Benzinga

Topics Economy

Top S&P500 movers in Wednesday's session ↗

September 17, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Gapping S&P500 stocks in Wednesday's session ↗

September 17, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Insulet Announces CFO Transition

September 16, 2025

From Insulet Corporation

Via Business Wire

3 Reasons Investors Love Insulet (PODD)

September 12, 2025

Insulet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18%. The stock now trades at $337, marking a 35.7% gain. This was partly thanks to its solid...

Via StockStory

Topics Stocks

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy

Which S&P500 stocks are moving on Wednesday? ↗

September 10, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

September 10, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.